ArticleAlzheimer's & dementia (New York, N. Y.)2015

Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab.

Mahesh N Samtani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.